Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2012, Vol. 10 ›› Issue (12): 1482-1489.doi: 10.3736/jcim20121223

• Original Experimental Research • Previous Articles     Next Articles

Effects of naringenin on allodynia and hyperalgesia in rats with chronic constriction injury-induced neuropathic pain

Kaulaskar Shyam, Bhutada Pravinkumar(), Rahigude Anand, Jain Dilpesh, Harle Uday   

  1. Post-Graduate Research Department, Sinhgad College of Pharmacy, Pune 411041, Maharashtra, IndiaPost-Graduate Research Department, Sinhgad College of Pharmacy, Pune 411041, Maharashtra, India
  • Received:2012-08-03 Accepted:2012-10-28 Online:2012-12-20 Published:2018-12-15

Objective: To study the analgesic effects of naringenin on chronic constriction injury (CCI) model of neuropathic pain.
Methods: After inducing of neuropathic pain by CCI, treatment with 25 and 50 mg/kg of naringenin and 10 mg/kg of pregabalin was given. Rats were evaluated for behavioral tests using Hargreaves apparatus for thermal hyperalgesia, pin prick test for tactile mechanical hyperalgesia and cold water-induced allodynia on days 0, 3, 5, 7, 14 and 21. At the end of study, oxidative stress parameters were measured.
Results: Naringenin showed ameliorating action against CCI-induced neuropathic pain in all the tested models. Also, naringenin attenuated the elevated levels of lipid peroxidation and nitric oxide, and restored the level of reduced glutathione.
Conclusion: The results of the present investigation suggest that naringenin exhibits analgesic effect in sciatic nerve injury model.

Key words: analgesics, sciatica, hyperalgesia, flavonoids, pain, oxidative stress

Figure 1

Effect of naringenin on CCI-induced neuropathic pain in thermal hyperalgesia model Data are expressed as mean±standard error of mean, and repeated measure of two-way analysis of variance followed by Bonferroni’s post test was used for the statistical analysis; n=6. **P<0.01, vs sham-operated group; △P<0.05,△△P<0.01, vs CCI control group. CCI: chronic constriction injury."

Figure 2

Effect of naringenin on CCI-induced neuropathic pain in cold allodynia model Data are expressed as mean±standard error of mean, and results obtained were analyzed by repeated two-way analysis of variance followed by Bonferroni’s post test, n=6. **P<0.01, vs sham-operated group; △P<0.05, △△P<0.01, vs CCI control group. CCI: chronic constriction injury."

Figure 3

Effect of naringenin on CCI-induced neuropathic pain in mechanical hyperalgesia model Data are expressed as mean±standard error of mean, and results obtained were analyzed by repeated two-way analysis of variance followed by Bonferroni’s post test. **P<0.01, vs sham-operated group; △△P<0.01, vs CCI control group. CCI: chronic constriction injury."

Figure 4

Effect of naringenin on CCI-induced neuropathic pain in exploratory behavior (Locomotor activity) test Data are expressed as mean±standard error of mean. Repeated measure of two-way analysis of variance followed by Bonferronis post test."

Figure 5

Effect of naringenin on oxidative stress markers in CCI-induced neuropathic pain model A: effect of naringenin on MDA level; B: effect of naringenin on GSH level; C: effect of naringenin on NO level. Data are expressed as mean±standard mean of error, and results obtained were analyzed by one-way analysis of variance followed by Tukey’s multiple comparison, n=6. **P<0.01, vs sham-operated group, △△P<0.01, vs CCI control group. MDA: malondialdehyde; GSH: reduced glutathione; NO: nitric oxide; CCI: chronic constriction injury."

[1] Naik AK, Tandan SK, Kumar D, Dudhgaonkar SP . Nitric oxide and its modulators in chronic constriction injury-induced neuropathic pain in rats. Eur J Pharmacol. 2006; 530(1-2):59-69.
doi: 10.1016/j.ejphar.2005.11.029 pmid: 16364289
[2] Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, Bushnell MC, Farrar JT, Galer BS, Haythornthwaite JA, Hewitt DJ, Loeser JD, Max MB, Saltarelli M, Schmader KE, Stein C, Thompson D, Turk DC, Wallace MS, Watkins LR, Weinstein SM . Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003; 60(11) : 1524-1534.
doi: 10.1001/archneur.60.11.1524
[3] Hama AT, Borsook D . Behavioral and pharmacological characterization of a distal peripheral nerve injury in the rat. Pharmacol Biochem Behav. 2005; 81(1):170-181.
doi: 10.1016/j.pbb.2005.03.009 pmid: 15894076
[4] Bouhassira D, Lanteri-Minet M, Attal N, Laurent B, Touboul C . Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008; 136(3):380-387.
doi: 10.1016/j.pain.2007.08.013
[5] Toth C, Lander J, Wiebe S . The prevalence and impact of chronic pain with neuropathic pain symptoms in the general population. Pain Med. 2009; 10(5):918-929.
doi: 10.1111/j.1526-4637.2009.00655.x
[6] Caviedes BE, Herranz JL . Advances in physiopathology and the treatment of neuropathic pain. Rev Neurol. 2002; 35(11): 1037-1048. Spanish.
doi: 10.1016/S0278-5846(02)00263-4 pmid: 12497311
[7] Hansson PT, Dickenson AH . Pharmacological treatment of perisdpheral neuropathic pain conditions based on shared commonalities despite multiple etiologies. Pain. 2005; 113(3) : 251-254.
doi: 10.1016/j.pain.2004.10.007
[8] Jensen TS, Madsen CS, Finnerup NB . Pharmacology and treatment of neuropathic pains. Curr Opin Neurol. 2009; 22(5) : 467-474.
doi: 10.1097/WCO.0b013e3283311e13 pmid: 19741531
[9] Bennett GJ, Xie YK . A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988; 33(1) : 87-107.
doi: 10.1016/0304-3959(88)90209-6
[10] Seltzer Z, Dubner R, Shir Y . A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 1990; 43(2):205-218.
doi: 10.1016/0304-3959(90)91074-S
[11] Kim SH, Chung JM . An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 1992 ; 50(3) : 355-363.
doi: 10.1016/0304-3959(92)90041-9
[12] DeLeo JA, Coombs DW, Willenbring S, Colburn RW, Fromm C, Wagner R, Twitchell BB . Characterization of a neuropathic pain model: sciatic cryoneurolysis in the rat. Pain. 1994; 56(1):9-16.
doi: 10.1016/0304-3959(94)90145-7 pmid: 8159445
[13] Decosterd I, Woolf CJ . Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain. 2000; 87(2) : 149-158.
doi: 10.1016/S0304-3959(00)00276-1
[14] Fox A, Gentry C, Patel S, Kesingland A, Bevan S . Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea-pig. Pain. 2003; 105(1-2):355-362.
doi: 10.1016/S0304-3959(03)00253-7
[15] Dowdall T, Robinson I, Meert TF . Comparison of five different rat models of peripheral nerve injury. Pharmacol Biochem Behav. 2005; 80(1):93-108.
doi: 10.1016/j.pbb.2004.10.016 pmid: 15652385
[16] Comelli F, Giagnoni G, Bettoni I, Colleoni M, Costa B . Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved. Phytother Res. 2008; 22(8):1017-1024.
doi: 10.1002/ptr.2401
[17] Kanter M . Effects of Nigella sativa and its major constituent, thymoquinone on sciatic nerves in experimental diabetic neuropathy. Neurochem Res. 2008; 33(1):87-96.
doi: 10.1007/s11064-007-9419-5
[18] Muthuraman A, Diwan V, Jaggi AS, Singh N, Singh D . Ameliorative effects of Ocimum sanctum in sciatic nerve transection-induced neuropathy in rats. J Ethno- pharmacol. 2008; 120(1):56-62.
doi: 10.1016/j.jep.2008.07.049 pmid: 18762236
[19] Babbar S, Marier JF, Mouksassi MS, Beliveau M, Vanhove GF, Chanda S, Bley K . Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain. Ther Drug Monit. 2009; 31(4):502-510.
doi: 10.1097/FTD.0b013e3181a8b200
[20] Muthuraman A, Singh N . Attenuating effect of Acorus calamus extract in chronic constriction injury induced neuropathic pain in rats: an evidence of anti-oxidative, anti- inflammatory, neuroprotective and calcium inhibitory effects. BMC Complement Altern Med. 2011 ; 11 : 24.
doi: 10.1186/1472-6882-11-24
[21] Amin B, Hosseinzadeh H . Evaluation of aqueous and ethanolic extracts of saffron, Crocus sativus L. , and its constituents, safranal and crocin in allodynia and hyperalgesia induced by chronic constriction injury model of neuropathic pain in rats. Fitoterapia. 2012 ; 83(5):888-895.
doi: 10.1016/j.fitote.2012.03.022
[22] Guimaraes AG, Gomes SV, Moraes VR, Nogueira PC, Ferreira AG, Blank AF, Santos AD, Viana MD, Silva GH, Quintans Junior LJ . Phytochemical characterization and antinociceptive effect of Lippia gracilis Schauer. J Nat Med. 2012; 66(3):428-434.
doi: 10.1007/s11418-011-0601-3 pmid: 22146971
[23] Wilcox LJ, Borradaile NM, Huff MW . Antiatherogenic properties of Naringenin, a Citrus flavonoid. Cardiovasc Drug Rev. 1999; 17(2):160-178.
doi: 10.1111/j.1527-3466.1999.tb00011.x
[24] Goldwasser J, Cohen PY, Yang E, Balaguer P, Yarmush ML, Nahmias Y . Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARalpha,PPARgamma and LXRalpha. PLoS One . 2010; 5(8): el2399.
[25] Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, Dexter DT . Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson’s disease. Free Radic Res. 2005; 39(10):1119-1125.
[26] Yi LT, Li CF, Zhan X, Cui CC, Xiao F, Zhou LP, Xie Y . Involvement of monoaminergic system in the antidepressant-like effect of the flavonoid naringenin in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2010 ; 34(7):1223-1228.
doi: 10.1016/j.pnpbp.2010.06.024
[27] Heo HJ, Kim DO, Shin SC, Kim MJ, Kim BG, Shin DH . Effect of antioxidant flavanone, naringenin, from Citrus junoson neuroprotection. J Agric Food Chem. 2004; 52(6) : 1520-1525.
doi: 10.1021/jf035079g pmid: 15030205
[28] Ribeiro IA, Rocha J, Sepodes B, Mota-Filipe H, Ribeiro MH . Effect of naringin enzymatic hydrolysis towards naringenin on the anti-inflammatory activity of both compounds. J Mol Catal B Enzym. 2008; 52- 53 : 13-18.
[29] Ortiz-Andrade RR, Sanchez-Salgado JC, Navarrete-Vazquez G, Webster SP, Binnie M, Garda-Jimenez S, Leon-Rivera I, Cigarroa-Vazquez P, Villalobos-Molina R, Estrada- Soto S . Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. Diabetes Obes Metab. 2008; 10(11):1097-1104.
doi: 10.1111/dom.2008.10.issue-11
[30] Rayidi S . Effect of Naringenin on carbohydrate metabolism in streptozotocin-nicotinamide induced diabetic rats. Biomirror. 2011 ; 2 : 1-9.
[31] Park JH, Lee JW, Paik HD, Cho SG, Nah SY, Park YS, Han YS . Cytotoxic effects of 7-O-butyl naringenin on human breast cancer MCF-7 cells. Food Sci Biotechnol. 2010; 19(3) : 717-724.
doi: 10.1007/s10068-010-0101-3
[32] Orsolic N, Gajski G, Garaj-Vrhovac V, Dikid D, Prskalo ZS, Sirovina D . DNA-protective effects of quercetin or naringenin in alloxan-induced diabetic mice. Eur J Pharmacol. 2011; 656(1-3):110-118.
doi: 10.1016/j.ejphar.2011.01.021 pmid: 21277296
[33] Qiang X, Satoh J, Sagara M, Fukuzawa M, Masuda T, Sakata Y, Muto G, Muto Y, Takahashi K, Toyota T . Inhibitory effect of troglitazone on diabetic neuropathy in streptozotocin-induced diabetic rats. Diabetologia. 1998; 41(11) : 1321-1326.
doi: 10.1007/s001250051072
[34] Churi SB, Abdel-Aleem OS, Tumber KK, Scuderi-Porter H, Taylor BK . Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats. J Pain. 2008; 9(7) : 639-649.
[35] Yamagishi S, Ogasawara S, Mizukami H, Yajima N, Wada R, Sugawara A, Yagihashi S . Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated- y-ligand, in insulin-deficient diabetic rats. J Neurochem. 2008; 104(2) : 491-499.
[36] Jain V, Jaggi AS, Singh N . Ameliorative potential of rosiglitazone in tibial and sural nerve transection-induced painful neuropathy in rats. Pharmacol Res. 2009 ; 59(6):385-392.
doi: 10.1016/j.phrs.2009.02.001
[37] Choi Y, Raja SN, Moore LC, Tobin JR . Neuropathic pain in rats is associated with altered nitric oxide synthase activity in neural tissue. J Neurol Sci. 1996; 138(1-2):14-20.
[38] Kitto KF, Haley JE, Wilcox GL . Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci Lett. 1992; 148(1-2):1-5.
doi: 10.1016/0304-3940(92)90790-E pmid: 1284437
[39] Kumar A, Meena S, Kalonia H, Gupta A, Kumar P . Effect of nitric oxide in protective effect of melatonin against chronic constriction sciatic nerve injury induced neuropathic pain in rats. Indian J Exp Biol. 2011 ; 49(9):664-671.
[40] Chao CL, Weng CS, Chang NC, Lin JS, Kao ST, Ho FM . Naringenin more effectively inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in macrophages than in microglia. Nutr Res. 2010 ; 30(12):858-864.
doi: 10.1016/j.nutres.2010.10.011
[41] Park HY, Kim GY, Choi YH . Naringenin attenuates the release of pro-inflammatory mediators from lipopo- lysaccharide-stimulated BV2 microglia by inactivating nuclear factor-k:B and inhibiting mitogen-activated protein kinases. Int J Mol Med. 2012; 30(1):204-210.
[42] Farghaly HS, Abdel-Zaher AO, Mostafa MG, Kotb HI . Comparative evaluation of the effect of tricyclic antidepressants on inducible nitric oxide synthase expression in neuropathic pain model. Nitric Oxide. 2012; 27(2):88-94.
doi: 10.1016/j.niox.2012.05.001
[43] Baluchnejadmojarad T, Roghani M . Effect of naringenin on intracerebroventricular streptozotocin-induced cognitive deficits in rat: a behavioral analysis. Pharmacology. 2006; 78(4) : 193-197.
doi: 10.1159/000096585
[44] Hargreaves K, Dubner R, Brown F, Flores C, Joris J . A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988; 32(1):77-88.
doi: 10.1016/0304-3959(88)90026-7 pmid: 202020202020202020202020
[45] Dirig DM, Salami A, Rathbun ML, Ozaki GT, Yaksh TL . Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli. J Neurosci Methods. 1997; 76(2):183-191.
[46] Upadhya MA, Dandekar MP, Kokare DM, Singru PS, Subhedar NK . Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats : behavioral and neuroan- atomical correlates. Neuropeptides. 2009; 43(4):303-314.
doi: 10.1016/j.npep.2009.05.003
[47] Quintao NL, Ferreira J, Beirith A, Campos MM, Calixto JB . Evaluation of the effects of the herbal product Catuama in inflammatory and neuropathic models of nociception in rats. Phytomedicine. 2008; 15(4) : 245-252.
doi: 10.1016/j.phymed.2007.03.015
[48] Erichsen HK, Blackburn-Munro G . Pharmacological characterisation of the spared nerve injury model of neuropathic pain. Pain. 2002 ; 98(1-2) : 151-161.
doi: 10.1016/S0304-3959(02)00039-8
[49] Okhawa H, Ohishi N, Yagi K . Assay for lipid peroxides in animal tissues by thiobarbituricacidreaction. Anal Biochem. 1979; 95(2) : 351-358.
doi: 10.1016/0003-2697(79)90738-3
[50] Bhutada P, Mundhada Y, Humane V, Rahigude A, Deshmukh P, Latad S, Jain K . Agmatine, an endogenous ligand of imidazoline receptor protects against memory impairment and biochemical alterations in streptozotocin- induced diabetic rats. Prog Neuropsychopharmacol Biol Psychiatry. 2012; 37(1):96-105.
[51] Ellman GL . Tissue sulfhydryl groups. Arch Biochem Biophys. 1959; 82(1):70-77.
doi: 10.1016/0003-9861(59)90090-6
[52] Bhutada P, Mundhada Y, Bansod K, Tawari S, Patil S, Dixit P, Umathe S, Mundhada D . Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes. Behav Brain Res. 2011; 220(1) : 30-41.
doi: 10.1016/j.bbr.2011.01.022
[53] Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR . Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem. 1982 ; 126(1):131-138.
doi: 10.1016/0003-2697(82)90118-X pmid: 7181105
[54] Jaggi AS, Singh N . Therapeutic targets for the management of peripheral nerve injury-induced neuropathic pain. CNS Neurol Disord Drug Targets. 2011; 10(5):589-609.
doi: 10.2174/187152711796235041
[55] Jin Y, Sato J, Yamazaki M, Omura S, Funakubo M, Senoo S, Aoyama M, Mizumura K . Changes in cardiovascular parameters and plasma norepinephrine level in rats after chronic constriction injury on the sciatic nerve. Pain. 2008; 135(3):221-231.
doi: 10.1016/j.pain.2007.05.020
[56] Naik AK, Tandan SK, Dudhgaonkar SP, Jadhav SH, Kataria M, Prakash VR, Kumar D . Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-L-cysteine in rats. Eur J Pain. 2006; 10(7) : 573-579.
[57] Annadurai T, Muralidharan AR, Joseph T, Hsu MJ, Thomas PA, Geraldine P . Antihyperglycemic and an-tioxidant effects of a flavanone, naringenin, in strepto- zotocin-nicotinamide-induced experimental diabetic rats. J Physiol Biochem. 2012; 68(3):307-318.
[58] Szkudelska K, Nogowski L, Nowicka E, Szkudelski T . In vivo metabolic effects of naringenin in the ethanol consuming rat and the effect of naringenin on adipocytes in vitro. J Anim Physiol Anim Nutr (Berl). 2007 ; 91(3-4):91-99.
doi: 10.1111/jpn.2007.91.issue-3-4
[59] Thiagarajan VR, Shanmugam P, Krishnan UM, Muth- uraman A, Singh N . Antinociceptive effect of Butea monosperma on vincristine-induced neuropathic pain model in rats. Toxicol Ind Health. 2012 Jan 27.
[60] Oliveira AC, Bertollo CM, Rocha LT, Nascimento EB Jr, Costa KA, Coelho MM . Antinociceptive and antiedem- atogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma. Eur J Pharmacol. 2007; 561(1-3):194-201.
[1] Gerli E.G. Herr, Fábio Goulart da Silva, Francisco José Cidral-Filho, Fabricia Petronilho, Lucinéia Gainski Danielski, Mariana Pereira de Souza Goldim, Afonso Shiguemi Inoue Salgado, Franciane Bobinski, Daniel Fernandes Martins, Eliane R. Winkelmann. Effects of the use of bioceramic wraps in patients with lower limb venous ulcers: A randomized double-blind placebo-controlled trial. Journal of Integrative Medicine, 2020, 18(1): 27-.
[2] Álisson de Carvalho Gonçalves, Einy Jéssika Siqueira Moreira, Guilherme Vannucchi Portari. Benfotiamine supplementation prevents oxidative stress in anterior tibialis muscle and heart. Journal of Integrative Medicine, 2019, 17(6): 423-429.
[3] Rebecca Kulbida, Alexander Mathes, Johannes Loeser. Beneficial effects of hirudotherapy in a chronic case of complex regional pain syndrome. Journal of Integrative Medicine, 2019, 17(5): 383-386.
[4] Pranay Soni, Rajesh Choudhary, Surendra H. Bodakhe. Effects of a novel isoflavonoid from the stem bark of Alstonia scholaris against fructose-induced experimental cataract. Journal of Integrative Medicine, 2019, 17(5): 374-382.
[5] Fang-yuan Wang, Jian Jia, Huan-huan Song, Cheng-ming Jia, Chang-bo Chen, Jing Ma. Icariin protects vascular endothelial cells from oxidative stress through inhibiting endoplasmic reticulum stress. Journal of Integrative Medicine, 2019, 17(3): 205-212.
[6] Stefania Lamponi, Anna Maria Aloisi, Claudia Bonechi, Marco Consumi, Alessandro Donati, Gemma Leone, Claudio Rossi, Gabriella Tamasi, Luana Ghiandai, Ersilia Ferrini, Paolo Fiorenzani, Ilaria Ceccarelli, Agnese Magnani. Evaluation of in vitro cell and blood compatibility and in vivo analgesic activity of plant-derived dietary supplements. Journal of Integrative Medicine, 2019, 17(3): 213-220.
[7] Arthur Yin Fan, Hui Ouyang, Xinru Qian, Hui Wei, David Dehui Wang, Deguang He, Haihe Tian, Changzhen Gong, Amy Matecki, Sarah Faggert Alemi. Discussions on real-world acupuncture treatments for chronic low-back pain in older adults. Journal of Integrative Medicine, 2019, 17(2): 71-76.
[8] Michelle T. Jesse, Mathew Kulas, Josephine Unitis, Nemie Beltran, Marwan Abouljoud. Acupuncture in living liver and kidney donors: a feasibility study. Journal of Integrative Medicine, 2019, 17(1): 3-7.
[9] Lucky Legbosi Nwidu, Yibala Ibor Oboma. Telfairia occidentalis (Cucurbitaceae) pulp extract mitigates rifampicin-isoniazid-induced hepatotoxicity in an in vivo rat model of oxidative stress. Journal of Integrative Medicine, 2019, 17(1): 46-56.
[10] Ralph Fernando Rosas, Aline Armiliato Emer, Ana Paula Batisti, Daniela Dero Ludtke, Bruna Lenfers Turnes, Franciane Bobinski, Francisco José Cidral-Filho, Daniel Fernandes Martins. Far infrared-emitting ceramics decrease Freund’s adjuvant-induced inflammatory hyperalgesia in mice through cytokine modulation and activation of peripheral inhibitory neuroreceptors. Journal of Integrative Medicine, 2018, 16(6): 396-403.
[11] Supakanya Kumkarnjana, Rutt Suttisri, Ubonthip Nimmannit, Thongchai Koobkokkruad, Chutichot Pattamadilok, Nontima Vardhanabhuti . Anti-adipogenic effect of flavonoids from Chromolaena odorata leaves in 3T3-L1 adipocytes. Journal of Integrative Medicine, 2018, 16(6): 427-434.
[12] Ching-Feng Su. Home care with acupuncture increased the quality of life in a patient with advanced cancer with neuropathic pain induced by bone metastasis: A case report. Journal of Integrative Medicine, 2018, 16(3): 208-210.
[13] Sepideh Hamdamian, Soheila Nazarpour, Masoumeh Simbar, Sepideh Hajian, Faraz Mojab, AtefehTalebi. Effects of aromatherapy with Rosa damascena on nulliparous women’s pain and anxiety of labor during first stage of labor. Journal of Integrative Medicine, 2018, 16(2): 120-125.
[14] Pathom Somwong, Rutt Suttisri. Cytotoxic activity of the chemical constituents of Clerodendrum indicum and Clerodendrum villosum roots. Journal of Integrative Medicine, 2018, 16(1): 57-61.
[15] Arthur Yin Fan, David W. Miller, Bonnie Bolash, Matthew Bauer, John McDonald, Sarah Faggert, Hongjian He, Yong Ming Li, Amy Matecki, Lindy Camardella, Mel Hopper Koppelman, Jennifer A.M. Stone, Lindsay Meade, John Pang. Acupuncture's Role in Solving the Opioid Epidemic: Evidence, Cost-Effectiveness, and Care Availability for Acupuncture as a Primary, Non-Pharmacologic Method for Pain Relief and Management-White Paper 2017. Journal of Integrative Medicine, 2017, 15(6): 411-425.
Full text



[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[5] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[6] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[7] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[8] Xi Lin, Jian-ping Liu. Tai chi for treating rheumatoid arthritis. Journal of Chinese Integrative Medicine, 2008, 6(1): 82
[9] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[10] Li Zhou, Hong-xing Zhang, Ling-guang Liu, Wen-jun Wan. Effect of electro-acupuncture at Fenglong (GV 16) on nitric oxide and endothelin in rats with hyperlipidemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 89-92